Multimodal molecular testing with GEP and #ddcfDNA predicts future graft dysfunction and cardiovascular death in #HeartTransplant recipients. @KiranKhush1
🔗: https://t.co/qazngbfx1a
We are ready for integration of cardiac energetics into routine care:
Bedside Integration of VA Coupling, Cardiac Energetics, and Advanced Hemodynamics in the Management of Heart Failure - JCF - Intersections https://t.co/W8qMK50NzJ
@JCFINT@JasonKatzMD@MarkBelkinMD
Our latest analysis from the SHORE registry now in @TheJHLT comprised of nearly 2000 pts with heart transplant
Read here about the risk of dual + GEP/dd-cfDNA
https://t.co/p1sXtXIPBw
@JeffTeuteberg@KiranKhush1@CareDx
☎️ out to all critical care cardiologists ❤️- looking for some shock ⚡️, transplant and MCS inclined 🧑⚕️ 👩⚕️ 👨⚕️ to join our squad @StVincentIN. Please contact myself or @SunitChaudhryMD if you want to learn more!
https://t.co/YGESPgoM7T
Congratulations to the ASCEND fellows! Thank you to the faculty who participated and shared their wisdom and experience over the last three programs. A special thanks to @shelleyhallmd @JeffTeuteberg and @AHajduczok for their passion and leadership!
Thrilled to announce that the one and only @JasonKatzMD will be the new Editor in Chief of JCF Intersections!
Excited to see all the incredible things he and the team accomplish as part of the @JCardFail Family
Let's do this! 🍾
@dranulala@ShashankSinhaMD@HFSA@DrMarthaGulati
The DOAC LVAD (Evaluation of the Hemocompatibility of the DOAC Apixaban vs Warfarin in LVAD) Phase II RCT out! DOAC was safe without an excess of HRAEs or deaths
https://t.co/4CipIJzKjv @JACCJournals#JACCHF@coconnormd@PalakShahMD@ShashankSinhaMD